Douglas Flora: Our second annual “State of AI in Precision Oncology 2024”
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post on LinkedIn:
“What better way to end 2024 than by joining AI in Precision Oncology for our second annual ‘State of AI in Precision Oncology 2024’ virtual summit? (and please consider sharing for reach, it is free to attend.)
Are you curious about where to begin with AI in oncology? Are you unsure which tools are ready for implementation or how to present AI solutions to leadership? Are you looking for ways to enroll more patients in clinical trials, boost efficiency, or reduce clinician burnout? We’ll be tackling these questions and more on December 12.
Join us – and >5,000 of your colleagues – for an extraordinary free summit packed with cutting-edge insights, expert-led discussions, and practical takeaways that could reshape your practice and accelerate your adoption of AI in precision oncology.
Confirmed Speakers:
- Debra Patt
- Leroy Hood
- Caroline Chung
- Vivek Subbiah
- Sanjay Juneja
- Rajeev Ronanki
- Sean Khozin
I don’t know if there’s a more knowledgeable lineup for these topics anywhere—these speakers are the Navy SEALs of AI in cancer care! Expect dynamic keynotes, in-depth panel discussions, and engaging fireside chats as some of the brightest minds in the field share their insights on how AI is transforming the landscape of precision oncology.
Don’t miss this unique opportunity to learn from the field’s top innovators and thought leaders. It’s time to explore the future of oncology – together.
Date: Thursday, December 12, 2024
Time: 8:00 am PT | 11:00 am ET | 17:00 CET
Register Now.
Sponsorships are still available. Contact Bill Levine or Jessica Shook to learn how your company can participate in the year’s most significant AI in Oncology event.”
More posts featuring Douglas Flora.
Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.
As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023